ImmuCell Corp (ICCC)
5.29
+0.04
(+0.76%)
USD |
NASDAQ |
May 09, 16:00
ImmuCell Gross Profit (Quarterly): 1.258M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.258M |
September 30, 2023 | 1.267M |
June 30, 2023 | 1.044M |
March 31, 2023 | 0.3008M |
December 31, 2022 | 0.9922M |
September 30, 2022 | 1.846M |
June 30, 2022 | 1.707M |
March 31, 2022 | 3.103M |
December 31, 2021 | 2.561M |
September 30, 2021 | 2.419M |
June 30, 2021 | 2.074M |
March 31, 2021 | 1.602M |
December 31, 2020 | 1.621M |
September 30, 2020 | 1.722M |
June 30, 2020 | 1.283M |
March 31, 2020 | 2.236M |
December 31, 2019 | 1.838M |
September 30, 2019 | 1.451M |
June 30, 2019 | 1.249M |
March 31, 2019 | 2.202M |
December 31, 2018 | 1.396M |
September 30, 2018 | 0.951M |
June 30, 2018 | 1.487M |
March 31, 2018 | 1.360M |
December 31, 2017 | 1.212M |
Date | Value |
---|---|
September 30, 2017 | 0.9359M |
June 30, 2017 | 0.9214M |
March 31, 2017 | 2.152M |
December 31, 2016 | 1.219M |
September 30, 2016 | 1.205M |
June 30, 2016 | 1.240M |
March 31, 2016 | 1.758M |
December 31, 2015 | 1.658M |
September 30, 2015 | 1.612M |
June 30, 2015 | 1.131M |
March 31, 2015 | 1.851M |
December 31, 2014 | 1.343M |
September 30, 2014 | 1.078M |
June 30, 2014 | 0.8785M |
March 31, 2014 | 1.150M |
December 31, 2013 | 0.6076M |
September 30, 2013 | 0.6157M |
June 30, 2013 | 0.7837M |
March 31, 2013 | 1.054M |
December 31, 2012 | 0.7502M |
September 30, 2012 | 0.621M |
June 30, 2012 | 0.6705M |
March 31, 2012 | 1.013M |
December 31, 2011 | 0.725M |
September 30, 2011 | 0.526M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.3008M
Minimum
Mar 2023
3.103M
Maximum
Mar 2022
1.662M
Average
1.621M
Median
Dec 2020
Gross Profit (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.815M |
Palatin Technologies Inc | 1.936M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |